- 1Department of Neurosurgery, The Second Affiliated Hospital of Kunming Medical University, Kunming, China
- 2Institute for Ecological Research and Pollution Control of Plateau Lakes, School of Ecology and Environmental Science, Yunnan University, Kunming, China
- 3Hematology and Rheumatology Department, The Pu’er People’s Hospital, Pu’er, China
- 4Department of Cardiovascular Surgery, The First People’s Hospital of Yunnan Province, Kunming, China
- 5Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, United States
- 6Department of Respiratory Medicine, Second Hospital of Kunming Medical University, Kunming, China
- 7Kunming College of Life Science, University of Chinese Academy of Sciences, Beijing, China
A Correction on
Over-expression of long non-coding RNA-AC099850.3 correlates with tumor progression and poor prognosis in lung adenocarcinoma
By Chen X, Guo J, Zhou F, Ren W, Pu J, Mutti L, Niu X and Jiang X (2022) Front. Oncol. 12:895708. doi: 10.3389/fonc.2022.895708
Error in Figure
In the published article, there was an error in Figure 11G as published. The representative picture of BRDU, H1975 cells was presented incorrectly. This occurred primarily because there were too many pictures taken with the microscope on the disc. Confusing duplicate document numbers led us to upload the wrong image. The corrected Figure 11G appears below.

Figure 11. lncRNA-AC099850.3 modulates LUAD cell proliferation and migration in vitro. (A) The relative expression level of AC099850.3 in lung adenocarcinoma cancerous cell lines, including H358, H1975 and A549 examined by Real-time RT-PCR, compared to normal human bronchial epithelial cell line: BEAS-2B. (B, C) Establishment of AC099850.3 knockdown cell lines in A549 and H1975 verified by Real-time RT-PCR (D–G) Knockdown of lncRNA AC099850.3 significantly inhibits cell proliferation as measured by CCK8 and BrdU assay. (H, I) knockdown of lncRNA AC099850.3 dramatically inhibits LUAD cells migration ability examined by transwell assay. ***P < 0.001. NC, Negative control; siRNA, AC099850.3 siRNA.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: lncRNA, lung adenocarcinoma, prognosis biomarker, immune infiltration, ceRNA, cell proliferation, cell migration
Citation: Chen X, Guo J, Zhou F, Ren W, Pu J, Mutti L, Niu X and Jiang X (2025) Correction: Over-expression of long non-coding RNA-AC099850.3 correlates with tumor progression and poor prognosis in lung adenocarcinoma. Front. Oncol. 15:1641207. doi: 10.3389/fonc.2025.1641207
Received: 04 June 2025; Accepted: 04 July 2025;
Published: 21 July 2025.
Edited and Reviewed by:
Sharon R Pine, University of Colorado Anschutz Medical Campus, United StatesCopyright © 2025 Chen, Guo, Zhou, Ren, Pu, Mutti, Niu and Jiang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xiulin Jiang, amlhbmd4aXVsaW5AbWFpbC5raXouYWMuY24=; Xiaoqun Niu, NjczNDA5MjU2QHFxLmNvbQ==; Luciano Mutti, bHVjaWFuby5tdXR0aUB0ZW1wbGUuZWR1; Jun Pu, cHVqdW4zMDNAYWxpeXVuLmNvbQ==
†These authors have contributed equally to this work